Bioidentical Progesterone Cream: The Honest Verdict on What It Can and Cannot Do

The short answer

This does not mean progesterone is useless or that "bioidentical" is a scam word. Micronized progesterone, which is chemically identical to the progesterone your ovaries make, is a real, FDA-approved medicine, taken orally, and it is the progesterone the North American Menopause Society (NAMS) 2022 position statement recognizes for endometrial protection alongside estrogen. The problem is not the molecule. The problem is the delivery format and the marketing: a jar of cream sold as a supplement is regulated differently from a prescription drug, and it has not been shown to deliver a dose that reliably protects the uterus.

This page lays out what the evidence and the regulators actually say, where OTC creams fall short, what the approved alternatives are, how the cost structures differ, and which symptoms mean you should stop self-treating and see a clinician. No fabricated study results, no invented before-and-after numbers, and no pitch to buy a specific jar.

The verdict, stated plainly

An over-the-counter product labeled 'bioidentical progesterone cream' is sold as a cosmetic or dietary supplement, not as an approved drug. That legal category is the whole story: it means the product has not been reviewed by the FDA for effectiveness as hormone therapy, and no manufacturer has had to prove that rubbing it on your skin delivers a dose that does anything specific in your body.

The single most important claim these products cannot support is endometrial protection. When estrogen stimulates the uterine lining and is not adequately opposed by a progestogen, that lining can build up abnormally over time. Approved progesterone dosing for menopausal hormone therapy exists precisely to prevent that. An OTC cream has not been established to provide it, so treating a cream as your 'progesterone half' of hormone therapy is the mistake to avoid.

If you only take one thing from this page: a cream that makes you feel calmer or helps you sleep has not thereby been shown to protect your uterus. Symptom relief and endometrial safety are two different questions, and the cream answers neither with FDA-reviewed evidence.

What 'bioidentical' actually means (and what it does not)

'Bioidentical' means a hormone molecule with the same chemical structure as the one your body produces. Progesterone sold as micronized progesterone is bioidentical in this sense, and so is the progesterone in most creams. So the word itself is accurate as far as the molecule goes. It is not a marketing invention.

Where the marketing overreaches is the implied leap from 'same molecule' to 'therefore natural, safe, and equivalent to prescription therapy.' Chemical identity says nothing about dose, absorption, or whether a given product reaches the tissue that needs it. A bioidentical molecule in an unregulated cream at an unknown delivered dose is not interchangeable with the same molecule in an FDA-approved oral capsule at a known dose.

Be especially wary of 'compounded bioidentical hormone therapy' pitched as a customized, safer alternative to standard prescriptions. Compounded preparations are mixed by a pharmacy and are generally not FDA-approved as finished products, so batch-to-batch consistency and delivered dose are not held to the same standard as a manufactured, approved drug.

Why endometrial protection is the real issue

For a person who still has a uterus and takes systemic estrogen (pill, patch, gel, or spray) to treat menopausal symptoms, estrogen alone stimulates the endometrium. Left unopposed over time, that stimulation raises the risk of the lining growing abnormally. Adding an adequate progestogen counteracts that effect. This is not an optional add-on; it is the reason progestogen is part of the regimen.

The NAMS 2022 hormone therapy position statement holds that a person with a uterus on systemic estrogen therapy needs adequate progestogen for endometrial protection. 'Adequate' is doing real work in that sentence: it means a dose and duration shown to protect the lining, not simply any product that contains progesterone in some amount.

This is exactly where OTC creams fail the test. Because their absorption is variable and they are not established to protect the endometrium, using a cream as the progestogen component while taking systemic estrogen can leave you exposed to estrogen's effect on the lining without proven cover. If you use any systemic estrogen, the progestogen side of the equation is a decision to make with a clinician, using a method with established protection.

FDA-approved oral micronized progesterone versus OTC cream

The cleanest way to see the gap is side by side. The two share the same molecule and almost nothing else that matters for safety and dosing.

Oral micronized progesterone is a prescription drug with a known dose, an FDA-reviewed label, and a recognized role in endometrial protection alongside estrogen. The OTC cream is a retail product with an unverified delivered dose and no approved therapeutic claim.

The absorption problem, in plain terms

Skin is a barrier, not a sponge. How much progesterone from a cream actually crosses into circulation depends on the formulation, the concentration, how much you apply, where you apply it, and your own skin. Because none of that is standardized in an OTC product, two people using the same jar the same way can end up with very different amounts in the body, and neither can know what they got.

This variability is not a minor footnote. Endometrial protection depends on reaching and sustaining an adequate progestogen effect. A delivery method that produces an unknown, inconsistent dose cannot be relied on for a job that requires a reliable one. That is the core reason regulators and menopause guidance do not treat these creams as hormone therapy.

It is worth separating two things a cream might do. It could, in some people, produce a local or systemic effect you notice. That is different from delivering a consistent, protective systemic dose. The first is plausible and personal; the second is what safety requires and what the cream has not been shown to provide.

What creams can and cannot do

What a cream cannot do, based on regulatory status and evidence: it cannot be relied on to protect the endometrium, it cannot substitute for the progestogen component of hormone therapy when you take systemic estrogen, and it cannot make a verified dosing claim, because its delivered dose is not standardized.

What a cream might do is harder to pin down honestly. Some people report feeling calmer, sleeping better, or noticing skin changes. Those experiences are real to the person having them, but they are not the same as demonstrated, reproducible efficacy, and they tell you nothing about whether your uterine lining is protected. Do not read a subjective improvement as evidence of endometrial safety.

The honest framing is this: if your goal is symptom relief and you have no uterus or take no systemic estrogen, a cream is a low-stakes personal choice with unproven benefit. If your goal is the progestogen half of hormone therapy, the cream is the wrong tool, and using it there is where the actual risk lives.

The real risk: relying on a cream for endometrial protection

The dangerous scenario is specific and worth naming: you have a uterus, you take systemic estrogen (prescribed or otherwise), and you use an OTC progesterone cream as your progestogen because it feels natural or is easier to get. In that setup, estrogen is acting on your endometrium while the progestogen cover is unproven and possibly inadequate.

This is not a hypothetical concern invented to sell prescriptions. The entire logic of pairing progestogen with estrogen exists because unopposed estrogen affects the uterine lining. Swapping the proven progestogen for an unverified cream removes the protection while keeping the estrogen exposure. That is the trade you cannot see happening and cannot feel.

If you are already in this situation, the move is not to panic or to stop everything abruptly, but to get the regimen reviewed by a clinician and, if indicated, to have any abnormal bleeding evaluated. The point is to replace guesswork with a method whose protection is established.

Approved and prescribed alternatives to know about

Oral micronized progesterone is the FDA-approved bioidentical progesterone used as the progestogen component with estrogen for people who have a uterus. It is the direct, evidence-backed answer to what most cream shoppers are actually looking for.

A levonorgestrel-releasing intrauterine system such as Mirena is FDA-approved for contraception and for heavy menstrual bleeding, per its label. It delivers a progestogen locally and provides no estrogen, so it does not treat hot flashes on its own; it is sometimes used off-label as the progestogen component of hormone therapy for endometrial protection, which is a decision for a clinician.

For a different menopausal complaint, painful sex due to menopause, vaginal prasterone (Intrarosa, a form of DHEA) is FDA-approved for moderate-to-severe dyspareunia, per its label. It is mentioned here only to make a point about categories: an approved, targeted product with a specific indication is a different thing from an oral DHEA supplement, which is not an FDA-approved drug and whose broader menopause and anti-aging claims are unproven. The same distinction separates approved progesterone from a cream.

Compounded, OTC, and prescription: how they differ

Shoppers often blur three categories that are legally and practically distinct. Getting them straight prevents most of the costly mistakes.

An OTC cream is a retail product you buy without a prescription; it is not approved hormone therapy. A compounded preparation is mixed by a pharmacy to a prescriber's order and is generally not an FDA-approved finished product, so its consistency is not held to the manufactured-drug standard. An FDA-approved prescription is a manufactured drug with a reviewed label and standardized dose.

What this costs, and why the price tag can mislead

We do not quote specific dollar figures here, because prices change and vary by pharmacy, plan, and location, and inventing numbers would be worse than useless. What is stable is the structure of how each option is priced, and that structure is what to reason about.

An OTC cream is a cash purchase off a shelf or website, with no insurance involved and no clinician visit; its sticker price can look cheap next to a prescription. That apparent savings is the trap: you are paying for a product that carries no approved hormone-therapy claim and no proven endometrial protection, so a low price buys you an unverified result.

A prescription for oral micronized progesterone may be covered by insurance in whole or part, may have a generic pathway, and may be discountable through pharmacy savings programs; the out-of-pocket cost depends on your plan and pharmacy. Compounded preparations are typically paid out of pocket and priced by the compounding pharmacy. Ask any prescriber and pharmacy directly for current pricing and coverage before deciding, and weigh cost against whether the option actually does the job you need.

How the menopause transition changes the picture

Perimenopause is staged clinically by your cycle pattern over time, not by a single hormone blood test. A period returning after a skipped stretch is common during the transition and does not by itself mean anything is wrong. This matters because cream marketing sometimes leans on a one-off hormone test to sell you a 'deficiency' story that the staging framework does not support.

The line that does matter is the final period. Bleeding that occurs 12 or more months after your last period is postmenopausal bleeding, and ACOG is clear that it always needs evaluation. No cream, supplement, or reassurance changes that rule.

During the transition, some people use combined hormonal contraception (pill, patch, or ring) for contraception and cycle control, but ACOG notes contraindications, for example smokers age 35 and older and certain cardiovascular risks or migraine with aura, and a clinician decides suitability. Note that this is contraception, not menopausal hormone therapy, and it is a separate conversation from progesterone for endometrial protection.

When to stop self-treating and see a clinician

Some situations are not DIY. Any bleeding 12 or more months after your final period, very heavy bleeding, or bleeding that worries you should be evaluated promptly by a clinician, not managed with an OTC product. Postmenopausal bleeding is never something to wait out or mask.

If you take systemic estrogen and have a uterus, treat your progestogen coverage as a medical decision, not a shopping decision. This is the exact scenario where an unproven cream can leave you exposed, and it is worth a visit to confirm you have established protection.

You should also loop in a clinician if you are combining products on your own, if a compounding pharmacy is steering you toward custom hormone blends, or if you have symptoms that a hormone test alone is being used to explain. A clinician who is licensed in your state can assess your history, your uterus status, and your actual options.

How to have the conversation and compare real options

Walk in with the specific questions that cut through marketing: Do I have a uterus and do I take any systemic estrogen? If yes, what is my established source of endometrial protection? Is oral micronized progesterone appropriate for me? Is a levonorgestrel IUD a reasonable off-label option in my case? Those questions move you from buying a jar to building a regimen.

If your interest is symptom relief rather than hormone therapy, say so plainly, and ask what has actual evidence for your specific symptom rather than what is trending. Naming the goal lets a clinician match you to something proven instead of something merely marketed.

When you are ready to look at providers, compare menopause and hormone-therapy providers licensed in your state, and bring this page's questions with you. The aim is not to get sold a product; it is to get a plan whose safety is established and whose dosing is real.

Frequently asked questions

Is bioidentical progesterone cream FDA-approved?

No. Over-the-counter bioidentical progesterone creams are sold as supplements or cosmetics, not as approved hormone therapy. They have not been reviewed by the FDA for effectiveness as hormone therapy, their absorption through skin is variable, and they are not established to protect the endometrium.

Can a progesterone cream protect my uterine lining if I take estrogen?

It is not established to. If you have a uterus and take systemic estrogen, the NAMS 2022 position statement holds that you need adequate progestogen for endometrial protection. An OTC cream delivers a variable, unverified dose and has not been shown to provide that protection, so relying on it for this purpose is the main risk to avoid.

Is 'bioidentical' just a marketing word?

The word itself is accurate; it means a molecule chemically identical to the progesterone your body makes, which is true of most creams and of prescription micronized progesterone. The overreach is implying that chemical identity makes an unregulated cream as safe or as effective as an FDA-approved, standardized-dose prescription. It does not.

What is the FDA-approved alternative to a progesterone cream?

Oral micronized progesterone is the FDA-approved bioidentical progesterone used as the progestogen component with estrogen for people who have a uterus. It has a known, standardized dose and a recognized role in endometrial protection, unlike an OTC cream.

Is compounded progesterone safer than OTC cream?

Compounded preparations are mixed by a pharmacy to a prescriber's order and are generally not FDA-approved finished products, so their dose consistency is not held to the manufactured-drug standard. Being prescription-obtained does not make a compounded product equivalent to an approved, standardized drug.

I feel better on a cream, isn't that proof it works?

Feeling better is real, but it is not evidence that your endometrium is protected or that the product delivered a consistent dose. Symptom relief and endometrial safety are separate questions. A subjective improvement should not be read as proof the cream is doing the protective job that hormone therapy requires.

What is the difference between progesterone cream and DHEA products?

They are different hormones with different approval status. Vaginal prasterone (Intrarosa, a DHEA product) is FDA-approved for moderate-to-severe painful sex due to menopause, per its label. Oral DHEA sold as a supplement is not an FDA-approved drug, and its broader menopause and anti-aging claims are unproven, similar to how an OTC progesterone cream lacks approved hormone-therapy claims.

I have bleeding after menopause and use a cream. What should I do?

Get evaluated promptly by a clinician. Bleeding 12 or more months after your final period is postmenopausal bleeding, and ACOG is clear it always needs evaluation. Do not use a cream, supplement, or reassurance to wait it out.

Primary sources

1. The 2022 hormone therapy position statement of NAMS. Menopause 2022. PMID 35797481.
2. ACOG, Hormone Therapy for Menopause.
3. ACOG, The Menopause Years.
4. ACOG, Perimenopausal Bleeding and Bleeding After Menopause.
5. FDA Prescribing Information, Mirena (levonorgestrel-releasing intrauterine system).
6. FDA Prescribing Information, Intrarosa (prasterone / vaginal DHEA) vaginal insert.
7. Stages of Reproductive Aging Workshop +10 (STRAW+10). PMID 22344196.